Longevity Acquisition Corp (Nasdaq: LOAC) is a blank-check special purpose acquisition company that completed its initial public offering in 2020, targeting the healthcare and life-sciences sector with a particular focus on longevity-related businesses. The company was formed to identify and consummate a merger, share exchange, asset acquisition, or similar business combination with one or more operating companies serving the growing longevity and healthy-aging market. The October 2020 Form 8-K filing, bearing accession number 0001104659-20-117217, reflects a material corporate event reported during the company's early post-IPO period. Investors and researchers tracking LOAC's deal activity, sponsor background, and current status can access the full data profile on SpacDesk — sign up at spacdesk.com for comprehensive SPAC coverage.